Not available
Quote | Aerie Pharmaceuticals Inc. (NASDAQ:AERI)
Last: | $15.25 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $15.25 |
High: | $0 |
Low: | $0 |
Volume: | 600 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Aerie Pharmaceuticals Inc. (NASDAQ:AERI)
Leveraging Alcon’s robust commercial capabilities and resources to drive further growth and access to Rocklatan and Rhopressa Acquisition adds pharmaceutical research and development capabilities and further expertise for future product pipeline Expands Al...
Aerie Pharmaceuticals' ( NASDAQ: AERI ) likely last day of trading on the Nasdaq will be on Nov. 18 as part of its merger with Alcon ( ALC ). With the acquisition, Alcon ( ALC ) gains Rocklatan and Rhopressa, eye drops to reduce intraocular pressure, as well a...
Message Board Posts | Aerie Pharmaceuticals Inc. (NASDAQ:AERI)
Subject | By | Source | When |
---|---|---|---|
Temp set back for $AERI today... | dealerschool2006 | investorshub | 09/16/2021 2:44:37 PM |
$SKYE + AERI = $$$$ | bobbleheadtwin | investorshub | 06/02/2021 5:58:50 PM |
Looking better. Gonna be a long haul back | Johnny_C | investorshub | 02/28/2021 8:59:02 PM |
News: $AERI Aerie Pharmaceuticals Inc ($AERI) Q2 2020 | whytestocks | investorshub | 08/08/2020 4:00:34 PM |
Tempted to buy more here - | Johnny_C | investorshub | 03/12/2020 5:52:18 PM |
News, Short Squeeze, Breakout and More Instantly...
Aerie Pharmaceuticals Inc. Company Name:
AERI Stock Symbol:
NASDAQ Market:
Aerie Pharmaceuticals Inc. Website:
Leveraging Alcon’s robust commercial capabilities and resources to drive further growth and access to Rocklatan and Rhopressa Acquisition adds pharmaceutical research and development capabilities and further expertise for future product pipeline Expands Al...
Third Quarter Glaucoma Franchise Net Revenues of $36.1 Million, up 23% over Third Quarter 2021 Previously Announced Agreement to be Acquired by Alcon; Transaction Expected to Close in the Fourth Quarter of 2022 Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a pharmaceut...
NEW YORK, NY / ACCESSWIRE / October 30, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Altra Industrial Motion Corp. (NA...